Skip to main content
    E

    Eledon Pharmaceuticals Inc (ELDN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.97
    -0.15 (-6.86%)

    Market Cap: $178.63M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Eledon Pharmaceuticals Inc (ELDN) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Eledon Pharmaceuticals (ELDN) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Eledon Pharmaceuticals reported EPS of -$0.18, above the -$0.20 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    55%(21/38)
    Avg Surprise
    -4.20%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.17
    Range-$0.22 - -$0.01
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    7 analysts

    Next Report

    ELDN has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, ELDN beat 22, missed 16 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 231.25% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.18-$0.20-$0.21 - -$0.15+10.00%BeatN/A41 up, 2 downNov 12, 2026
    Jun 30, 2026-$0.19-$0.19-$0.19 - -$0.090.00%In lineN/A42 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.33-$0.26N/A-26.92%MissN/A20 up, 1 downMay 13, 2026
    Dec 31, 2025-$0.10-$0.20-$0.26 - -$0.17+50.00%BeatN/A63 up, 0 downMar 19, 2026
    Sep 30, 2025-$0.21-$0.25-$0.32 - -$0.16+16.00%BeatN/A62 up, 2 downNov 14, 2025
    Jun 30, 2025-$0.13-$0.23-$0.31 - -$0.13+43.48%BeatN/A63 up, 0 downAug 14, 2025
    Mar 31, 2025-$0.08-$0.30-$0.32 - -$0.28+73.33%BeatN/A30 up, 1 downMay 14, 2025
    Dec 31, 2024-$0.95-$0.33-$0.37 - -$0.29-189.44%MissN/A60 up, 0 downMar 20, 2025
    Sep 30, 2024-$0.32-$0.31-$0.37 - -$0.20-3.23%MissN/A40 up, 0 downNov 12, 2024
    Jun 30, 2024-$1.06-$0.32-$0.36 - -$0.23-231.25%MissN/A50 up, 0 downAug 19, 2024
    Mar 31, 2024-$0.34-$0.33-$0.41 - -$0.33-3.03%MissN/A40 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.29-$0.39-$0.45 - -$0.35+25.64%BeatN/A50 up, 0 downMar 28, 2024
    Sep 30, 2023-$0.35-$0.41-$0.72 - -$0.38+14.63%BeatN/A50 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.40-$0.45-$0.52 - -$0.39+11.11%BeatN/A50 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.75-$0.74-$0.74 - -$0.46-1.35%MissN/A20 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.69-$0.70-$0.78 - -$0.50+1.43%BeatN/A40 up, 0 downMar 30, 2023
    Sep 30, 2022-$0.73-$0.69-$0.71 - -$0.64-5.80%MissN/A50 up, 0 downNov 14, 2022
    Jun 30, 2022-$0.65-$0.72-$0.75 - -$0.62+9.72%BeatN/A50 up, 0 downAug 11, 2022
    Mar 31, 2022-$0.69-$0.68-$0.86 - -$0.52-1.47%MissN/A40 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.60-$0.79-$0.92 - -$0.57+24.05%BeatN/A5N/AMar 24, 2022
    Sep 30, 2021-$0.66-$0.65-$0.71 - -$0.58-1.54%MissN/A5N/ANov 11, 2021
    Jun 30, 2021-$0.50-$3.76N/A+86.70%BeatN/A4N/AAug 12, 2021
    Mar 31, 2021-$0.57-$0.32-$0.41 - -$0.19-78.13%MissN/A4N/AMay 13, 2021
    Dec 31, 2020-$0.69-$1.76-$3.60 - -$0.16+60.80%BeatN/A3N/AMar 30, 2021
    Sep 30, 2020-$5.51-$1.75N/A-214.86%MissN/AN/AN/ANov 16, 2020
    Jun 30, 2020-$2.70-$2.97N/A+9.09%BeatN/AN/AN/AAug 14, 2020
    Mar 31, 2020-$3.49-$2.88N/A-21.18%MissN/AN/AN/AMay 15, 2020
    Dec 31, 2019-$3.24-$4.68N/A+30.77%BeatN/AN/AN/AMar 17, 2020
    Sep 30, 2019-$3.96-$7.29N/A+45.68%BeatN/AN/AN/ANov 13, 2019
    Jun 30, 2019-$6.30-$7.65N/A+17.65%BeatN/AN/AN/AAug 13, 2019
    Mar 31, 2019-$9.36-$8.73N/A-7.22%MissN/AN/AN/AMay 14, 2019
    Dec 31, 2018-$8.82-$7.20N/A-22.50%MissN/AN/AN/AMar 28, 2019
    Sep 30, 2018-$6.66-$7.20N/A+7.50%BeatN/AN/AN/ANov 13, 2018
    Jun 30, 2018-$6.12-$5.58N/A-9.68%MissN/AN/AN/AAug 7, 2018
    Mar 31, 2018-$6.48-$5.22N/A-24.14%MissN/AN/AN/AApr 2, 2018
    Sep 30, 2017-$7.74N/AN/AN/AN/AN/AN/AN/ANov 8, 2017
    Jun 30, 2017-$23.76-$48.60N/A+51.11%BeatN/AN/AN/AAug 9, 2017
    Mar 31, 2017-$27.54-$48.60N/A+43.33%BeatN/AN/AN/AMay 3, 2017
    Dec 31, 2016-$27.54-$55.08N/A+50.00%BeatN/AN/AN/AMar 3, 2017
    Sep 30, 2016-$66.42-$68.85N/A+3.53%BeatN/AN/AN/ANov 3, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.52, after -$2.67 the year before. It was -$325.62 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.52N/A
    Dec 31, 2024-$2.67N/A
    Dec 31, 2023-$1.79N/A
    Dec 31, 2022-$2.76N/A
    Dec 31, 2021-$2.33N/A
    Dec 31, 2020-$12.39N/A
    Dec 31, 2019-$22.86N/A
    Dec 31, 2018-$87.12N/A
    Dec 31, 2016-$273.78N/A
    Dec 31, 2015-$325.62N/A

    Frequently Asked Questions About ELDN

    When is Eledon Pharmaceuticals's next earnings date?

    Eledon Pharmaceuticals's next earnings report is expected for Mar 17, 2027.

    Did ELDN beat earnings estimates last quarter?

    Yes. Eledon Pharmaceuticals reported EPS of -$0.18 for the quarter ended Sep 30, 2026, above the -$0.20 estimate, a 10.00% surprise.

    What EPS do analysts expect from ELDN next quarter?

    The consensus EPS estimate for Eledon Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.17 from 7 analysts, with estimates from -$0.22 to -$0.01.

    How often does ELDN beat earnings estimates?

    Eledon Pharmaceuticals beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -2.94%.